retatrutide phase 2 nejm 2023 weight loss percent 48 weeks for Obesity: Weight-Loss Data Early trial data for retatrutide

[Google Scholar] Aksenova MV, Silvers JM, Aksenov MY, Nath A, Ray PD, Mactutus CF, Booze RM (2006) HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity

Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market, where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed

For sermorelin, the primary objective marker is serum IGF-1 levels

Aversive stimulus differentially triggers subsecond dopamine release in reward regions